Nöel Milpied - Concepedia

Author

Nöel Milpied

Also Known As

Esmiol, Sophie, Greinix, H, Kerstin Schäfer-Eckart, M. Mora, M.-A. Billes, Milpied, Milpied, N., Milpied, Noel, N MILPIED, N Milpied

799

Publications

29.3K

Citations

H-Index

149

Concepts

All Affiliations

Sorbonne Université Inserm Hôpital Saint-Louis Hôpital Cardiologique du Haut-Lévêque Centre Hospitalier Universitaire de Nantes

About

Nöel Milpied is an author at Sorbonne Université specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	57	165	13.8K
2	Health Sciences	32	59	2.9K
3	Allergy	4	4	112
4	Public Health	1	1	39
5	Biomedical Engineering	1	1	21

Nöel Milpied

323

Publications

27.2K

Citations

H-Index

Page 1

	Year	Citations
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group Michael Pfreundschuh, Lorenz Trümper, Anders Österborg, The Lancet Oncology Hematological MalignancyLymphoid NeoplasiaMabthera International TrialMedicinePathology	2006	2.1K
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma Michael Wang, Javier Muñoz, André Goy, New England Journal of Medicine	2020	1.7K
Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis David W. Denning, Patricia Ribaud, Nöel Milpied, Clinical Infectious Diseases Antifungal AgentAntifungal AgentsAcute IaMedicinal FungiAcute Invasive Aspergillosis	2002	842
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group Michael Pfreundschuh, Evelyn Kuhnt, Lorenz Trümper, The Lancet Oncology Hematological MalignancyLymphoid Neoplasia6-Year ResultsMabthera International TrialMedicine	2011	796
Follicular lymphoma international prognostic index. Pascal Roy, Philippe Colombat, Josephine M White, PubMed	2004	627
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study Caroline Charlier, Élodie Perrodeau, Alexandre Leclercq, The Lancet Infectious Diseases Prognostic FactorsFoodborne IllnessClinical FeaturesMicrobiologyInfection Control	2017	556
Randomized Trial of Bone Marrow Versus Lenograstim-Primed Blood Cell Allogeneic Transplantation in Patients With Early-Stage Leukemia: A Report From the Société Française de Greffe de Moelle Didier Blaise, Mathieu Kuentz, Cécile Fortanier, Journal of Clinical Oncology	2000	377
Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients Nöel Milpied, B. Vasseur, Nathalie Parquet, Annals of Oncology Lymphoid NeoplasiaTransplantationImmunosuppressive TherapyImmunologyHematology	2000	376
Initial Treatment of Aggressive Lymphoma with High-Dose Chemotherapy and Autologous Stem-Cell Support Nöel Milpied, Éric Deconinck, Fanny Gaillard, New England Journal of Medicine	2004	341
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial Delphine Rossille, M Gréssier, Diane Damotte, Leukemia Hematological MalignancyLymphoid NeoplasiaMedicineMalignant Blood DisorderHigh Level	2014	322

Page 1